Invesco
DRUG

Invesco’s Bright Minds Biosciences DRUG Stock Holding History

Invesco’s Portfolio DRUG Stock Details DRUG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$282K Sell
4,016
-2,280
-36% -$179K ﹤0.01% 3462
2026
Q1 		$459K Buy
6,296
+2,098
+50% +$169K ﹤0.01% 3198
2025
Q4 		$328K Buy
+4,198
New +$281K ﹤0.01% 3348

Other funds holding DRUG

JT
Jupiter Topco New York $245B AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Invesco's DRUG Position: Q2 2026 in Review

Invesco reduced its Bright Minds Biosciences (DRUG) stake by 36% in Q2 2026, selling an estimated $179K and leaving 4,016 shares worth $282K. The position accounts for ﹤0.01% of the portfolio, ranked #3462.

Invesco first reported a position in DRUG in Q4 2025 and has held it in 3 quarters since. The position peaked at $459K in Q1 2026. 100 funds tracked by Wall St. Rank hold DRUG as of Q2 2026.

  • Invesco held 4,016 shares of Bright Minds Biosciences worth $282K as of Q2 2026.
  • Invesco sold 2,280 Bright Minds Biosciences shares in Q2 2026, an estimated $179K.
  • Bright Minds Biosciences made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #3462 holding.
  • Invesco first reported a position in Bright Minds Biosciences in Q4 2025 and has held it in 3 quarters since.
  • Invesco's Bright Minds Biosciences position peaked at $459K in Q1 2026.
  • 100 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.